Skip to main content

Table 6 Clinical Characteristics of Subjects at baseline and end of Study

From: Exploring the extended role of the community pharmacist in improving blood pressure control among hypertensive patients in a developing setting

   Intervention group (IG) Control Group (CG)
Variables   Baseline After 6 Months Mean difference (95% CI) p-Value Baseline After 6 months Mean difference (95% CI) p-Value
Blood Pressure SBP Mean 152.3 143.4 9.28 (12.79 to 5.79) 0.000 147.2 145.8 1.34 (4.95 to −2.28) 0.463
DBP Mean 87.6 78.5 9.040 (12.77 to 5.30) 0.000 90.7 91.2 −0.535 (1.77 to −2.84) 0.644
BMI Mean 27.5 26.0 1.463 (2.33 to −0.59) 0.001 27.1 27.6 −0.098 (0.66 to −0.86) 0.798
Adherence Mean 5.5 6.2 −0.693 (−0.08 to −1.30) 0.027 4.3 3.9 0.408 (0.765–0.052) 0.026
Smoking n (%) 2 (2.7) 2 (2.7)   1.000 0 (0) 0(0)   1.102
Consumption of Salty foods n (%) 28 (37.3) 15 (20.0)   0.011 19 (26.8) 16 (22.5)   0.508
Alcohol n (%) Regular n (%) 8 (10.6) 2 (2.7)   0.000 9 (12.7) 3 (4.2)   .005
Exercise n (%) n(%) 24 (32.0) 58 (77.3)   0.000 32 (45.1) 22 (31.0)   0.031